Neovadiol Meno 5 Bi-Serum

Vichy Neovadiol Meno 5 Bi-Serum launched on World Menopause Day in October 2022. It addresses a reality the beauty industry often ignores: menopausal skin is not just aging skin. Hormonal shifts cause specific changes—declining estrogen drops lipid production, slows cell turnover, depletes glycosaminoglycans, and alters pigmentation in ways generic anti-aging products do not target. Vichy ran clinical trials on peri- and post-menopausal women instead of extrapolating from twenty-somethings.

The bi-phase format is the first thing you notice. The bottle shows two layers—a golden oil phase and a clear water phase—that you shake before each use. This is functional, not aesthetic. Separating squalane and apricot kernel oil from niacinamide and glycolic acid preserves stability and ensures both phases deliver full potency when freshly emulsified on your skin.

On the skin, it feels lightweight for a product targeting dryness-prone menopausal complexions. The shaken emulsion spreads like silky water, absorbs within thirty seconds, and leaves a subtle luminosity without grease. This serum disappears into your routine, making it wearable under makeup or sunscreen.

The active roster is thoughtful. Niacinamide at an estimated three percent handles brightening and barrier support by stimulating the ceramide production that estrogen depletion slows. Glycolic acid at roughly two percent provides daily exfoliation to address the sluggish cell turnover that makes menopausal skin look dull and textured. These workhorses use concentrations that prioritize daily tolerability over dramatic single-use impact.

The formula’s signature ingredient is Pro-Xylane (hydroxypropyl tetrahydropyrantriol), a L’Oréal-patented xylose derivative that targets glycosaminoglycan synthesis in the dermis. A 2017 multi-center randomized study in Acta Dermato-Venereologica tested a Pro-Xylane complex on 240 post-menopausal women and found improvements in facial sagging, skin radiance, and firmness over 60 days. This research used the target demographic rather than a general population, which differentiates it from most ingredients in this space.

Squalane provides a biomimetic emollient to replace the sebum production lost during menopause. Ascorbyl glucoside—a stable vitamin C derivative—and adenosine support brightening and anti-wrinkle claims.

The honest assessment: This serum contains Alcohol Denat. and Parfum. This is a puzzling choice for skin that often becomes more reactive during hormonal transitions. Many women develop new sensitivities during perimenopause, making fragrance and drying alcohol an unnecessary risk. Some retailers list this as alcohol-free, which is incorrect—check the INCI list. Isopropyl isostearate appears high in the formula and carries comedogenic potential, though the lightweight texture and low overall comedogenic risk seem to mitigate this for most users.

The packaging earns mixed marks. The weighted glass bottle looks premium and shows the bi-phase separation, but the nozzle applicator dispenses inconsistently. Many users transfer the product to a separate dropper bottle, a packaging failure for a thirty-nine-dollar product. At thirty-nine dollars for thirty milliliters, this French pharmacy serum is a moderate price, but twice-daily use lasts only six to eight weeks. There is no larger size, meaning consistent use costs roughly three hundred dollars a year.

Vichy’s clinical data shows a thirteen percent improvement in firmness and fourteen percent in radiance for perimenopausal women over two months, plus a twenty-two percent reduction in dark spot appearance for post-menopausal users. These are incremental, real improvements.

The product works best as part of a system. Layer it under a ceramide-rich moisturizer to seal in actives and add occlusive protection. Always use sunscreen in the morning; even at this low concentration, glycolic acid increases photosensitivity.

The Meno 5 Bi-Serum addresses the multi-front skin challenges of hormonal transition in one lightweight, daily step. It is not for everyone, and ingredient compromises prevent a perfect recommendation. But for women navigating menopause who want a formula built for specific skin changes and backed by relevant clinical data, this serum earns its place on the shelf.